Evaluation of Near Visual Acuity With ODYSIGHT, a Smartphone Based Medical

Updated 06/21/2024

Status Completed

Clinical Trial Summary

This study evaluates the level of agreement between visual parameters tested using OdySight, a mobile application, and standards in office methods.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Near Vision

Clinical Trial Details

NCT number	NCT03457441
Study type	Interventional
Source	Tilak Healthcare
Contact
Status	Completed
Phase	N/A
Start date	March 20, 2018
Completion date	July 24, 2018

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06045299` - Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia	Phase 3
	Completed	`NCT05359380` - The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
	Recruiting	`NCT04739085` - Level of Agreement Between Clinical Defocus Curves and the Web-based Democritus Digital Acuity Reading Test wDDART
	Not yet recruiting	`NCT05594537` - The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation
	Completed	`NCT04242836` - Development and Validation of a Digital Optotype for Near Vision in Greek Language.
	Completed	`NCT04907955` - Visual Performance Following Implantation of Presbyopia Correcting IOLs	N/A
	Completed	`NCT05005624` - Validation of an Activities-of-daily-living Framework at Different Light Conditions
	Completed	`NCT04059289` - Intermediate Vision in a Driving Simulator Environment: Comparison of the J&J EYHANCE With a Conventional Monofoc. IOL
	Completed	`NCT05753189` - Phase 3 Safety Study for the Treatment of Presbyopia Subjects	Phase 3
	Completed	`NCT04618224` - Development and Validation of an Internet-based Near and Intermediate-vision Reading Test
	Completed	`NCT05656027` - Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia	Phase 3
	Completed	`NCT05431543` - Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia	Phase 2
	Recruiting	`NCT05564832` - Pharmacological Treatment of Presbyopia	Early Phase 1
	Completed	`NCT05728944` - Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia	Phase 3